Skip to content

LKFT - Lakefront Biotherapeutics NV - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchL

Lakefront Biotherapeutics NV

LKFT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

L

LKFTLakefront Biotherapeutics NV

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $37.78
52-wk low: $25.68
Prev close: $30.24
Mkt cap: $1.83B
P/E: 2.6x
Fwd P/E: 344.8x

Smart money

Checking federal contract awards

Coverage gaps for LKFT

No tracked fund holdings this quarter
No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report

Financials

Fundamentals

Is the business strong?

Fairly priced and profitable.

Net margin: 60.2%
P/E: 2.64
Forward P/E: 344.83
Market cap: $1.8B

Valuation

P/S1.94
P/B0.48

Quality

Operating margin-358.9%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: LKFT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.83B
Beta: 0.11

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Beta

0.11

P/S

1.9x

P/B

0.5x

Profit margin

+60.2%

Op margin

-358.9%

ROE

+16.3%

10-K

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

EPS expected

-$0.39

-$1.00 to $0.23

Revenue expected

$6.1M

2 analysts

Last 30 days

0up2down

Analysts cutting estimates

Estimate drift

+0.10

Change in 30 days

ROE16.3%

ROA10.7%

Growth

Beta0.11